Cigna Group (NYSE:CI) Stock Rating Upgraded by Zacks Research

Cigna Group (NYSE:CIGet Free Report) was upgraded by Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Monday,Zacks.com reports.

A number of other equities research analysts have also weighed in on the company. Guggenheim reaffirmed a “buy” rating and set a $318.00 target price on shares of Cigna Group in a research report on Tuesday, December 2nd. Sanford C. Bernstein restated a “market perform” rating and set a $307.00 price target on shares of Cigna Group in a research note on Tuesday. TD Cowen lowered their price objective on shares of Cigna Group from $387.00 to $333.00 and set a “buy” rating for the company in a research note on Tuesday, November 4th. Raymond James Financial reiterated a “strong-buy” rating on shares of Cigna Group in a report on Monday, November 3rd. Finally, Wolfe Research reduced their price target on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, October 15th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $333.04.

View Our Latest Stock Report on Cigna Group

Cigna Group Price Performance

Cigna Group stock opened at $284.77 on Monday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76. The stock has a market cap of $76.07 billion, a price-to-earnings ratio of 12.56, a price-to-earnings-growth ratio of 1.00 and a beta of 0.26. The firm has a 50-day moving average of $271.29 and a two-hundred day moving average of $289.50. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The company’s revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Insider Activity at Cigna Group

In other Cigna Group news, CEO David Cordani acquired 4,134 shares of the firm’s stock in a transaction dated Monday, November 3rd. The stock was purchased at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the acquisition, the chief executive officer owned 157,935 shares in the company, valued at approximately $38,201,317.80. This trade represents a 2.69% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Central Pacific Bank Trust Division boosted its holdings in Cigna Group by 17.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 4,964 shares of the health services provider’s stock worth $1,366,000 after acquiring an additional 739 shares in the last quarter. Avior Wealth Management LLC raised its position in shares of Cigna Group by 2.8% in the 4th quarter. Avior Wealth Management LLC now owns 1,665 shares of the health services provider’s stock valued at $458,000 after purchasing an additional 45 shares during the last quarter. Red Spruce Capital LLC boosted its stake in Cigna Group by 2.5% in the 4th quarter. Red Spruce Capital LLC now owns 9,334 shares of the health services provider’s stock worth $2,569,000 after purchasing an additional 224 shares in the last quarter. Miller Global Investments LLC acquired a new stake in Cigna Group in the 4th quarter worth approximately $701,000. Finally, GK Wealth Management LLC purchased a new stake in Cigna Group during the 4th quarter worth approximately $203,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Company Profile

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Stories

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.